Evidence map›Paper›PMID 37965396›Full record

ReviewCureus2023

Transforming Medical Paradigms: A Cutting-Edge Review of Genomic and Robotic Medical and Surgical Approaches in the Battle Against Diabetes, Hypertension, and Cardiovascular Issues.

Yousaf Tanveer, Sailakshmn Sanipini, Rafeef Khleif, Tamar Tsenteradze, Abubakar Gapizov, Han Grezenko, Maryam Affaf, Ali M Abdelaziz, Abdur Rehman, Umar Zia and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yousaf TanveerUrology, Craigavon Area Hospital, Craigavon, GBR.
Sailakshmn SanipiniMedical School, Xavier University School of Medicine, Oranjestad, ABW.
Rafeef KhleifMedical School, Xavier University School of Medicine, Oranjestad, ABW.
Tamar TsenteradzeGeneral Surgery, Tbilisi State Medical Univerity, Tbilisi, GEO.
Abubakar GapizovGeneral Surgery, American University of Antigua, Saint George, ATG.
Han GrezenkoTranslational Neuroscience, Barrow Neurological Institute, Phoenix, USA.
Maryam AffafInternal Medicine, Women's Medical and Dental College, Abbotabad, PAK.
Ali M AbdelazizInternal Medicine, Alexandria University Faculty of Medicine, Alexandria, EGY.
Abdur RehmanSurgery, Mayo Hospital, Lahore, PAK.
Umar ZiaInternal Medicine, Khyber Medical University, Peshawar, PAK.
Huda JamaInternal Medicine, Nishtar Medical University, Multan, PAK.
Abdullah ShehryarInternal Medicine, Allama Iqbal Medical College, Lahore, PAK.
Syed Naveed MohsinGeneral Surgery, Cavan General Hospital, Cavan, IRL.
Chukwuyem EkhatorNeuro-Oncology, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, USA.
Rehman KhanInternal Medicine, Mayo Hospital, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article provides an in-depth review of the current state of management for diabetes, hypertension, and cardiovascular disease, focusing on advancements from genomics to robotics. It explores the role of genomic markers in personalized medicine, offering tailored treatment options for these chronic conditions. The article also examines the efficacy of various pharmacological and surgical interventions, including bariatric surgery for diabetes and device-based treatments for hypertension. A comparative analysis is presented to evaluate the cost-effectiveness and patient outcomes between medical and surgical approaches. The review concludes that while personalized medicine and minimally invasive surgical techniques show promise, more high-quality comparative research is needed. The ultimate goal is to integrate these emerging technologies within a framework of evidence-based medicine to improve patient outcomes and health equity.

Indexed as

clinical genomicscvadiabetes mellitusfuture managementhypertension

Identifiers

PMID37965396
PMCPMC10641027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.